We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Omega Diagnostics Group Plc | LSE:ODX | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.20 | 2.00 | 2.40 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMODX
RNS Number : 1062O
Omega Diagnostics Group PLC
27 January 2023
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Director/PDMR Shareholding
Omega (AIM: ODX), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that on 26 January 2023 it received notification that Jag Grewal, Chief Executive Officer, and Chris Lea, Chief Financial Officer, had each purchased 1,000,000 ordinary shares of 4 pence each in the Company ("Ordinary Shares"), at a price of 3.4839 pence each.
A summary of each Directors resultant holdings is below:
Director Board Position Existing number of Ordinary Shares Total beneficial holding of Ordinary Ordinary Shares Purchased Shares following these acquisitions Number of Ordinary Approximate % of Shares Company's issued share capital -------------------- Jag Grewal CEO 1,025,834 1,000,000 2,025,834 0.85 % ---------------- -------------------- -------------------- -------------------- -------------------- Chris Lea CFO 1,030,908 1,000,000 2,030,908 0.85% ---------------- -------------------- -------------------- -------------------- --------------------
Contacts:
Omega Diagnostics Group PLC www.omegadx.com Jag Grewal, Chief Executive Officer via Walbrook PR Chris Lea, Chief Financial Officer finnCap Ltd Tel: 020 7220 0500 Geoff Nash/Edward Whiley/George Dollemore (Corporate Finance) Alice Lane/Charlotte Sutcliffe (ECM) Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com Paul McManus Mob: 07980 541 893 Lianne Applegarth Mob: 07584 391 303 Sam Allen Mob: 07502 558 258
About Omega Diagnostics Group PLC
Omega (AIM: ODX) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition .
www.omegadx.com
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.
Notification of transactions of persons discharging managerial responsibilities and persons closely associated with them
Details of the person discharging managerial responsibilities 1 / person closely associated a) Name Jag Grewal ------------------------- ------------------------------------- Reason for the notification 2 ---------------------------------------------------------------- a) Position/status Chief Executive Officer ------------------------- ------------------------------------- b) Initial notification Initial Notification /Amendment ------------------------- ------------------------------------- Details of the issuer, emission allowance market participant, 3 auction platform, auctioneer or auction monitor ---------------------------------------------------------------- a) Name Omega Diagnostics Group PLC ------------------------- ------------------------------------- b) LEI 2138007U9P4BTZTYIR92 ------------------------- ------------------------------------- Details of the transaction(s): section to be repeated for 4 (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ---------------------------------------------------------------- a) Description Ordinary Shares of 4 pence each of the financial instrument, type of instrument Identification ISIN: GB00B1VCP282 code ------------------------- ------------------------------------- b) Nature of Ordinary Shares purchased the transaction ------------------------- ------------------------------------- c) Price(s) and Price(s) Volume(s) volume(s) ---------- 3.4839 pence 1,000,000 -------------- ---------- ------------------------- ------------------------------------- d) Aggregated See above information -Aggregated volume - Price ------------------------- ------------------------------------- e) Date of the 26.01.2023 transaction ------------------------- ------------------------------------- f) Place of the London Stock Exchange transaction ------------------------- ------------------------------------- Details of the person discharging managerial responsibilities 1 / person closely associated a) Name Chris Lea ------------------------- ------------------------------------- Reason for the notification 2 ---------------------------------------------------------------- a) Position/status Chief Financial Officer ------------------------- ------------------------------------- b) Initial notification Initial Notification /Amendment ------------------------- ------------------------------------- Details of the issuer, emission allowance market participant, 3 auction platform, auctioneer or auction monitor ---------------------------------------------------------------- a) Name Omega Diagnostics Group PLC ------------------------- ------------------------------------- b) LEI 2138007U9P4BTZTYIR92 ------------------------- ------------------------------------- Details of the transaction(s): section to be repeated for 4 (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ---------------------------------------------------------------- a) Description Ordinary Shares of 4 pence each of the financial instrument, type of instrument Identification ISIN: GB00B1VCP282 code ------------------------- ------------------------------------- b) Nature of Ordinary Shares purchased the transaction ------------------------- ------------------------------------- c) Price(s) and Price(s) Volume(s) volume(s) ---------- 3.4839 pence 1,000,000 -------------- ---------- ------------------------- ------------------------------------- d) Aggregated See above information -Aggregated volume - Price ------------------------- ------------------------------------- e) Date of the 26.01.2023 transaction ------------------------- ------------------------------------- f) Place of the London Stock Exchange transaction ------------------------- -------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHGCGDBXXDDGXR
(END) Dow Jones Newswires
January 27, 2023 04:36 ET (09:36 GMT)
1 Year Omega Diagnostics Chart |
1 Month Omega Diagnostics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions